Equities

Proteome Sciences PLC

PRM:LSE

Proteome Sciences PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)3.01
  • Today's Change0.10 / 3.44%
  • Shares traded127.15k
  • 1 Year change-51.26%
  • Beta0.0933
Data delayed at least 20 minutes, as of Sep 26 2024 12:36 BST.
More ▼

Profile data is unavailable for this security.

About the company

Proteome Sciences plc is a specialist provider of contract proteomics services. The Company’s services enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. Its principal activities involve protein biomarker research and development. It uses high-sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic and therapeutic applications. SysQuant and TMT MS2 are unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents for multiplex quantitative proteomics.

  • Revenue in GBP (TTM)4.04m
  • Net income in GBP-4.08m
  • Incorporated1993
  • Employees35.00
  • Location
    Proteome Sciences PLCCoveham House, Downside Bridge RoadADDLESTONE KT11 3EPUnited KingdomGBR
  • Phone+44 20 7043 2116Fax+44 20 3637 7516
  • Websitehttps://www.proteomics.com/
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Deltex Medical Group plc1.78m-1.29m2.23m37.002.23m37.00
Image Scan Holdings Plc2.56m-11.06k2.81m14.002.81m14.00
Aptamer Group PLC1.04m-7.01m4.51m54.004.51m54.00
Myhealthchecked PLC10.98m-159.00k5.72m10.005.72m10.00
Surgical Innovations Group Plc12.01m-509.00k5.93m101.005.93m101.00
Feedback plc886.00k-3.49m6.20m24.006.20m24.00
Rua Life Sciences PLC2.19m-1.44m6.98m33.006.98m33.00
Cambridge Nutritional Sciences PLC9.77m-328.00k8.03m94.008.03m94.00
Proteome Sciences plc4.04m-4.08m8.69m35.008.69m35.00
Genedrive PLC272.00k-5.00m11.02m43.0011.02m43.00
Genincode PLC2.16m-7.02m11.68m36.0011.68m36.00
Data as of Sep 26 2024. Currency figures normalised to Proteome Sciences PLC's reporting currency: UK Pound GBX

Institutional shareholders

34.68%Per cent of shares held by top holders
HolderShares% Held
Vulpes Investment Management Pte Ltd.as of 13 Apr 202367.79m22.97%
Hargreaves Lansdown Asset Management Ltd.as of 03 Sep 202414.63m4.96%
Jarvis Investment Management Ltd.as of 03 Sep 20248.75m2.97%
James Brearley & Sons Ltd.as of 03 Sep 20243.33m1.13%
Rowan Dartington & Co. Ltd. (Broker)as of 03 Sep 20242.36m0.80%
Walker Crips Investment Management Ltd.as of 03 Sep 20241.88m0.64%
IG Markets Ltd.as of 03 Sep 20241.35m0.46%
Winterflood Securities Ltd (Market-Maker)as of 03 Sep 2024898.00k0.30%
J. M. Finn & Co. Ltd.as of 03 Sep 2024728.00k0.25%
HSBC Global Asset Management (UK) Ltd.as of 03 Sep 2024643.00k0.22%
More ▼
Data from 11 Apr 2024 - 03 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.